High-affinity T cell receptors for adoptive cell transfer

被引：3

作者：

Isser, Ariel ^{[1
]}

Schneck, Jonathan P. ^{[2
,3
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Sch Med, Dept Pathol Med & Oncol, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Immunol Program, Inst Cellular Engn, Baltimore, MD 21205 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2019年 / 129卷 / 01期

基金：

美国国家科学基金会;

关键词：

CANCER REGRESSION; GENE-THERAPY; ANTIGEN; CD4(+); MELANOMA; IMMUNITY; MICE;

D O I：

10.1172/JCI125471

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Adoptive cell transfer (ACT) of engineered T cell receptors (TCRs) for cancer immunotherapy has evolved from simple gene transfer of isolated TCRs to various affinity enhancement techniques that overcome limitations imposed by central and peripheral tolerance on TCR affinity. In the current issue of the JCI, Poncette et al. used mice with human TCR alpha beta and HLA gene loci to discover CD4(+) TCRs of optimal affinity for cancer testis antigen (CTA) NY-ESO-1. They combined this TCR with a previously discovered NY-ESO-1-specific CD8(+) TCR in an ACT fibrosarcoma tumor model to demonstrate the importance of T cell help in mediating antitumor responses.

引用

页码：69 / 71

页数：3

共 50 条

[21] Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies
Stone, Jennifer D.
Kranz, David M.
FRONTIERS IN IMMUNOLOGY, 2013, 4
[22] High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies
Cinar, Oezcan
Brzezicha, Bernadette
Grunert, Corinna
Kloetzel, Peter Michael
Beier, Christin
Peuker, Caroline Anna
Keller, Ulrich
Pezzutto, Antonio
Busse, Antonia
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
[23] Selection of affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10
Border, Ellen
Sanderson, Joseph P.
Weissensteiner, Thomas
Hyland, Natalie
Holdich, Tom
Brophy, Francine
Amado, Rafael
Gerry, Andrew
Pumphrey, Nicholas
CANCER RESEARCH, 2018, 78 (13)
[24] Adoptive T-cell transfer in melanoma
Itzhaki, Orit
Levy, Daphna
Zikich, Dragoslav
Treves, Avraham J.
Markel, Gal
Schachter, Jacob
Besser, Michal J.
IMMUNOTHERAPY, 2013, 5 (01) : 79 - 90
[25] Adoptive transfer of T-cell immunity
Kessels, HWHG
Wolkers, MC
Schumacher, TNM
TRENDS IN IMMUNOLOGY, 2002, 23 (05) : 264 - 269
[26] Vaccines and adoptive T-cell transfer
Dreno, B.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 6 - 6
[27] High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
Sim, Malcolm J. W.
Lu, Jinghua
Spencer, Matthew
Hopkins, Francis
Tran, Eric
Rosenberg, Steven A.
Long, Eric O.
Sun, Peter D.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (23) : 12826 - 12835
[28] High affinity T-cell receptors for targeting B-cell malignancies
Heemskerk, Mirjam H. M.
HUMAN GENE THERAPY, 2014, 25 (11) : A15 - A15
[29] HIGH-AFFINITY IL-2 RECEPTORS ON A HODGKINS DERIVED CELL-LINE
TESCH, H
HERRMANN, T
ABTS, H
DIAMANTSTEIN, T
DIEHL, V
LEUKEMIA RESEARCH, 1990, 14 (11-12) : 953 - 960
[30] Identification of high-affinity T cell receptors against HLA-A2 restricted epitopes of shared T cell antigen CD5 as a treatment option for T cell malignancies
Cakmak-Goeruer, N.
Belbaraka, E.
Rhein, S.
Eckert, C.
Schwartz, S.
Keller, U.
Blakenstein, T.
Pezzutto, A.
Busse, A.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 102 - 102

← 1 2 3 4 5 →